期刊文献+

Red blood cell distribution width derivatives in alcohol-related liver cirrhosis and metabolic-associated fatty liver disease 被引量:4

下载PDF
导出
摘要 BACKGROUND Looking for undiscovered blood markers of liver fibrosis and steatosis still remains an issue worth exploring.There are still plenty of unresolved issues related to the actual role of hematological indices as potential markers of liver function.AIM To study red blood cell distribution width(RDW),RDW-to-platelet ratio(RPR)and RDW-to-lymphocyte ratio(RLR) in alcohol-related liver cirrhosis(ALC) and metabolic-associated fatty liver disease(MAFLD).METHODS The study group was composed of 302 people:142 patients with ALC and 92 with MAFLD;68 persons were included as controls.RDW,RPR and RLR were measured in each person.Indirect and direct parameters of liver fibrosis were also assessed [aspartate transaminase to alkaline transaminase ratio,aspartate transaminase to platelet ratio index(APRI),fibrosis-4(FIB-4),gamma-glutamyl transpeptidase to platelet ratio(GPR),procollagen I carboxyterminal propeptide,procollagen Ⅲ aminoterminal propeptide,transforming growth factor-α,plateletderived growth factor AB,laminin].MELD score in ALC patients and nonalcoholic fatty liver disease(NAFLD) fibrosis score together with BARD score were obtained in the MAFLD group.The achieved results were compared to controls.Then a correlation between assessed markers was done.Diagnostic value of each investigated parameter and its suggested cut-off in the research group RESULTS RDW,RPR and RLR values turned out to be significantly higher in ALC and MAFLD groups compared to controls(ALC:P<0.0001;NAFLD:P<0.05,P<0.0001 and P<0.0001,respectively).RPR correlated positively with MELD score(P<0.01) and indirect indices of liver fibrosis(FIB-4 and GPR;P<0.0001) in ALC patients;negative correlations were found between PDGF-AB and both:RDW and RPR(P<0.01 and P<0.0001,respectively).RPR correlated positively with NAFLD fibrosis score and APRI(P<0.0001) in the MAFLD group;a positive relationship was observed between RDW and FIB-4,too(P<0.05).AUC values and suggested cut-offs for RDW,RPR and RLR in ALC patients were:0.912(>14.2%),0.965(>0.075) and 0.914(>8.684),respectively.AUC values and suggested cut-offs for RDW,RPR and RLR in MAFLD patients were:0.606(>12.8%),0.724(>0.047) and 0.691(>6.25),respectively.CONCLUSION RDW with its derivatives appear to be valuable diagnostic markers in patients with ALC.They can also be associated with a deterioration of liver function in this group.
出处 《World Journal of Gastroenterology》 SCIE CAS 2022年第38期5636-5647,共12页 世界胃肠病学杂志(英文版)
基金 The survey was accepted by the local ethics committee of the Medical University of Lublin(No.KE-0254/86/2016).
  • 相关文献

参考文献1

二级参考文献17

  • 1N. Malandrino,W. C. Wu,T. H. Taveira,H. B. Whitlatch,R. J. Smith.Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes[J]. Diabetologia . 2012 (1)
  • 2GarethMorris‐Stiff,RocioLopez,LisaYerian,Ariel E.Feldstein.Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease[J]. Liver International . 2012 (2)
  • 3Sandra Mili?,Ivana Mikola?evi?,Mladen Radi?,Goran Hauser,Davor ?timac.Clinical Utility of Red Cell Distribution Width in Alcoholic and Non-alcoholic Liver Cirrhosis[J]. Collegium Antropologicum . 2011 (2)
  • 4Lee, Woong Soo,Kim, Think-You.Relation Between Red Blood Cell Distribution Width and Inflammatory Biomarkers in Rheumatoid Arthritis[J]. Archives of Pathology & Laboratory Medicine . 2010 (4)
  • 5Chetan V. Hampole,Amit K. Mehrotra,Thenappan Thenappan,Mardi Gomberg-Maitland,Sanjiv J. Shah.Usefulness of Red Cell Distribution Width as a Prognostic Marker in Pulmonary Hypertension ? ? Conflicts of interest: Dr. Gomberg-Maitland has received research grant support from Actelion Pharmaceuticals Ltd., Allschwil, Switzerland; CoTherix, Inc., South San Francisco, California; Encysive Pharmaceuticals Inc., Houston, Texas; Gilead Sciences Inc., Foster City, California; Eli Lilly/ICOS, Indianapolis, Indiana; Pfizer Inc., New York, New York; and United Therapeutics, Silver Spring, Maryland. Dr. Gomberg-Maitland has served as a consultant and/or on advisory boards for Encysive Pharmaceuticals Inc., Gilead Sciences Inc., Pfizer Inc., and United Therapeutics. Dr. Shah has received research grant support from Actelion Pharmaceuticals Ltd. (Entelligence Young Investigator Award) and is also the recipient of a Scientist Development Grant from the American Heart Association, Dallas, Texas.[J]. The American Journal of Cardiology . 2009 (6)
  • 6Lippi, Giuseppe,Targher, Giovanni,Montagnana, Martina,Salvagno, Gian Luca,Zoppini, Giacomo,Guidi, Gian Cesare.Relation Between Red Blood Cell Distribution Width and Inflammatory Biomarkers in a Large Cohort of Unselected Outpatients[J]. Archives of Pathology & Laboratory Medicine . 2009 (4)
  • 7Mariana Lazo,Jeanne Clark.The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective[J]. Semin Liver Dis . 2008 (04)
  • 8Chizobam Ani,Bruce Ovbiagele.Elevated red blood cell distribution width predicts mortality in persons with known stroke[J]. Journal of the Neurological Sciences . 2008 (1)
  • 9Marcello Tonelli,Frank Sacks,Malcolm Arnold,Lemuel Moye,Barry Davis,Marc Pfeffer.Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease[J]. Circulation . 2008 (2)
  • 10G. Michael Felker,Larry A. Allen,Stuart J. Pocock,Linda K. Shaw,John J.V. McMurray,Marc A. Pfeffer,Karl Swedberg,Duolao Wang,Salim Yusuf,Eric L. Michelson,Christopher B. Granger.Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure[J]. Journal of the American College of Cardiology . 2007 (1)

共引文献7

同被引文献24

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部